In VivoArtificial intelligence was more than a buzzword in 2024; it shaped pharmaceutical industry investments throughout the year, with multiple billion-dollar partnerships and acquisitions across the drug
ScripWho: GSK and Relation Therapeutics What: The UK major has linked up with fellow London-based group Relation on two “multi-program strategic collaborations” which will focus on the identification an